10,529 Shares in Electromed, Inc. (NYSE:ELMD) Acquired by Wilmington Savings Fund Society FSB

Wilmington Savings Fund Society FSB acquired a new position in shares of Electromed, Inc. (NYSE:ELMD) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 10,529 shares of the company’s stock, valued at approximately $226,000. Wilmington Savings Fund Society FSB owned about 0.12% of Electromed at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also bought and sold shares of ELMD. Pekin Hardy Strauss Inc. bought a new position in Electromed during the 2nd quarter worth approximately $522,000. Navellier & Associates Inc. acquired a new stake in Electromed during the 3rd quarter worth approximately $368,000. Marshall Wace LLP acquired a new stake in Electromed during the 2nd quarter worth approximately $256,000. Walleye Capital LLC acquired a new stake in Electromed during the 3rd quarter worth approximately $274,000. Finally, Hunter Associates Investment Management LLC raised its holdings in Electromed by 12.3% during the 3rd quarter. Hunter Associates Investment Management LLC now owns 102,450 shares of the company’s stock worth $2,199,000 after buying an additional 11,250 shares during the period. Institutional investors own 40.82% of the company’s stock.

Electromed Stock Performance

Shares of ELMD stock opened at $28.06 on Wednesday. The company has a market capitalization of $237.33 million, a P/E ratio of 38.86 and a beta of 0.29. The company’s 50 day moving average price is $26.14 and its two-hundred day moving average price is $19.69. Electromed, Inc. has a 52 week low of $9.81 and a 52 week high of $31.31.

Electromed (NYSE:ELMD) last announced its earnings results on Tuesday, November 12th. The company reported $0.16 EPS for the quarter, topping the consensus estimate of $0.03 by $0.13. The firm had revenue of $14.67 million for the quarter. Electromed had a net margin of 11.34% and a return on equity of 15.32%.

Insider Activity

In other news, Director Andrew Summers sold 17,463 shares of Electromed stock in a transaction that occurred on Monday, December 2nd. The shares were sold at an average price of $30.09, for a total value of $525,461.67. Following the sale, the director now directly owns 189,838 shares in the company, valued at $5,712,225.42. This trade represents a 8.42 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 14.00% of the stock is owned by corporate insiders.

Electromed Company Profile

Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions.